At the World Health Organization’s annual tobacco treaty negotiations, tobacco companies attempted to convince delegates that e-cigarettes are safer alternatives to traditional cigarettes. The negotiations were closed to corporate interests, but that didn’t stop company representatives from attending by wearing press badges and hosting elaborate conference-adjacent parties. (New York Times)

After a competitive pitch process, Publicis Media has won GlaxoSmithKline’s $1.7 billion media business. GSK’s European and U.S. media accounts were previously handled by MediaCom and PHD, respectively. Publicis has created a dedicated agency unit for the business. (Campaign via MM&M)

The FDA has expanded the approved use of Gardasil 9, Merck’s human papillomavirus vaccine, from people between the ages of nine and 26 to those between the ages of nine and 45. About 80 million Americans are estimated to be infected with some form of HPV. The expansion means insurers will likely cover the cost of the vaccine for those within the expanded age bracket. (CNN)

Pharma companies are loving the Trump administration’s reworked North American free trade agreement, known as USMCA. (Huffington Post) Pharmaceutical Research and Manufacturers of America praised the agreement’s protection of intellectual property and other standards “that will pave the way for the next generation of treatments and cures.” (PhRMA)

A Yale University study has revealed how difficult it can be for patients to obtain their medical records. (JAMA) The process is riddled with discrepancies, costs, and, in some cases, unreachable medical records departments. (Forbes)